Major depressive disorder (MDD) is one of the most serious diseases and now becomes a major public health problem in the world. The pathogenesis of depression remains poorly understood. Fibroblast growth factors (FGFs) belong to a large family of growth factors that are involved in brain development during early periods as well as maintenance and repair throughout adulthood. In recent years, studies have found a correlation between the members of the FGF system and depression. These signaling molecules may be expected to be biomarkers for the diagnosis and prognosis of MDD, and may provide new drug targets for the treatment of depression. Here, we reviewed the correlation between some members of the FGF system and depression
Major depressive disorder (MDD) is one of the leading causes of global disability. It is a risk fact...
International audienceBackground: The study of clinically related biological indicators in Major Dep...
Background: There is an increasing evidence that the Brain-Derived Neurotrophic Factor (BDNF) could ...
The neurotrophic hypothesis posits that changes in the expression and function of growth factors in ...
Previous research has shown that fibroblast growth factor 2 protein (FGF2) can act as an anxiolytic ...
The occurrence of depressive disorder has long been attributed to changes in monoamines, with the fo...
Background: Since the neurotrophic hypothesis of depression was formulated, conflicting results have...
In this review, we propose a broader view of the role of the fibroblast growth factor (FGF) family i...
Background: Since the neurotrophic hypothesis of depression was formulated, conflicting results have...
BACKGROUND: The neurotrophic hypothesis of major depressive disorder (MDD) postulates that the patho...
In the last several years a large number of studies have demonstrated the neurobiological and clinic...
Objective The precise mechanism of major depressive disorder (MDD) is poorly understood. On the basi...
Many neuropsychiatric disorders are thought to result from subtle changes in neural circuit formatio...
Fibroblast growth factor 21 (FGF21) is an important metabolic regulator of glucose homeostasis and l...
In the last several years a large number of studies have demonstrated the neurobiological and clinic...
Major depressive disorder (MDD) is one of the leading causes of global disability. It is a risk fact...
International audienceBackground: The study of clinically related biological indicators in Major Dep...
Background: There is an increasing evidence that the Brain-Derived Neurotrophic Factor (BDNF) could ...
The neurotrophic hypothesis posits that changes in the expression and function of growth factors in ...
Previous research has shown that fibroblast growth factor 2 protein (FGF2) can act as an anxiolytic ...
The occurrence of depressive disorder has long been attributed to changes in monoamines, with the fo...
Background: Since the neurotrophic hypothesis of depression was formulated, conflicting results have...
In this review, we propose a broader view of the role of the fibroblast growth factor (FGF) family i...
Background: Since the neurotrophic hypothesis of depression was formulated, conflicting results have...
BACKGROUND: The neurotrophic hypothesis of major depressive disorder (MDD) postulates that the patho...
In the last several years a large number of studies have demonstrated the neurobiological and clinic...
Objective The precise mechanism of major depressive disorder (MDD) is poorly understood. On the basi...
Many neuropsychiatric disorders are thought to result from subtle changes in neural circuit formatio...
Fibroblast growth factor 21 (FGF21) is an important metabolic regulator of glucose homeostasis and l...
In the last several years a large number of studies have demonstrated the neurobiological and clinic...
Major depressive disorder (MDD) is one of the leading causes of global disability. It is a risk fact...
International audienceBackground: The study of clinically related biological indicators in Major Dep...
Background: There is an increasing evidence that the Brain-Derived Neurotrophic Factor (BDNF) could ...